Demografske karakteristike i spektar komorbiditeta kod osoba sa mišićnom tenzionom disfonijom: retrospektivna studija preseka

  • Jelena Sotirović Military Medical Academy, Clinic for Otorhinolaryngology, Belgrade, Serbia; †University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Maša Petrović University of Belgrade, Faculty of Medicine, Belgrade, Serbia; Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
  • Milanko Milojević Military Medical Academy, Clinic for Otorhinolaryngology, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Nenad Baletić Military Medical Academy, Clinic for Otorhinolaryngology, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Ognjen Čukić Military Medical Academy, Clinic for Otorhinolaryngology, Belgrade, Serbia
  • Ivan Zaletel Institute for Histology and Embryology “Aleksandar Đ. Kostić”, Belgrade, Serbia
Ključne reči: komorbiditet;, demografija;, glas, poremećaji;, prevalenca;, srbija

Sažetak


Uvod/Cilj. Mišićna tenziona disfonija (MTD) je jedan od najčešćih poremećaja glasa. Cilj rada bio je da se ispitaju demografske karakteristike i prevalencija komorbiditeta kod pacijenata kojima je postavljena dijagnoza MTD. Metode. Retrospektivnom studijom preseka analizirane su demografske karakteristike i komorbiditeti kod 87 pacijenata kojima je postavljena dijagnoza tokom jednogodišnjeg perioda. Rezultati. Prosečna starost pacijenata bila je 49,2 godine (opseg 18–84 godina), a 79,3% je bilo mlađe od 65 godina. Ženski pol činio je 73,6%. Nije utvđena statistički značajna razlika u pušačkom statusu između muškaraca i žena (χ2 = 0,624; p ˃ 0,05). Od 87 pacijenata, 43 (49,4%) su bile osobe koje se bave profesijama koje zahtevaju intenzivnu upotrebu glasa. Među ovim pacijentima, 20 (46,5%) su bili nastavnici u školi, 8 (18,6%) prodavci, 5 (11,6%) profesionalni pevači, 3 (7,0%) vaspitači u vrtiću, 3 (7,0%) predavači, 2 (4,6%) psiholozi, 1 (2,3%) logoped i 1 (2,3%) fitnes instruktor. Sekundarna MTD dijagnostikovana je kod 36 (41,4%) pacijenata. Najčešći klinički nalazi dijagnostikovani kod osoba sa sekundarnom MTD bili su čvorići na glasnim žicama kod 24 pacijenta (66,7%). Prevalencija komorbiditeta bila je sledeća: blago do umereno oštećenje sluha (9,2%), postnazalna sekrecija (31,0%), preosetljivost na uobičajene inhalatorne alergene (31,0%), astma ili hronična opstruktivna bolest pluća (18,4%), poremećaj rada štitaste žlezde (17,2%) i anamnestički podaci o gastroezofagealnoj refluksnoj bolesti (21,8%). Zaključak. MTD se češće javlja kod žena i osoba koje se bave profesijama koje zahtevaju intenzivnu upotrebu glasa. Zbog visoke prevalencije komorbiditeta kod pacijenata kojima je postavljena dijagnoza MTD, neophodni su detaljna anamneza i dodatna ispitivanja kako bi se odredio konačan plan lečenja.

 

Reference

Van Houtte E, Claeys S, D'haeseleer E, Wuyts F, Van Lierde K. An examination of surface EMG for the assessment of muscle tension dysphonia. J Voice 2013; 27(2): 177–86.

Khoddami SM, Nakhostin Ansari N, Izadi F, Talebian Moghadam S. The assessment methods of laryngeal muscle activity in muscle tension dysphonia: a review. ScientificWorldJournal 2013; 2013: 507397.

Van Houtte E, Van Lierde K, Claeys S. Pathophysiology and treatment of muscle tension dysphonia: a review of the cur-rent knowledge. J Voice 2011; 25(2): 202–7.

Garaycochea O, Navarrete JMA, Del Río B, Fernández S. Muscle Tension Dysphonia: Which Laryngoscopic Features Can We Rely on for Diagnosis? J Voice 2019; 33(5): 812.e15–8.

Jafari N, Salehi A, Meerschman I, Izadi F, Ebadi A, Talebian S, et al. A Novel Laryngeal Palpatory Scale (LPS) in Patients with Muscle Tension Dysphonia. J Voice 2020; 34(3): 488.e9–27.

Da Cunha Pereira G, de Oliveira Lemos I, Dalbosco Gadenz C, Cassol M. Effects of Voice Therapy on Muscle Tension Dys-phonia: A Systematic Literature Review. J Voice 2018; 32(5): 546–52.

Koufman JA, Isaacson G. The spectrum of vocal dysfunction. Otolaryngol Clin North Am 1991; 24(5): 985–8.

Jacks A, Kavookjian H, Kraft S. Comparative Evaluation and Management of Dysphonia Between Adults <65 and ≥65 Years of Age. Otolaryngol Head Neck Surg 2021; 165(1): 142–8.

Altman KW, Atkinson C, Lazarus C. Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005; 19(2): 261–7.

Sataloff RT. Professional voice users: the evaluation of voice disorders. Occup Med 2001; 16(4): 633–47.

Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Influence of Occupation on Self-perceived Vocal Prob-lems in Patients With Voice Complaints. J Voice 2018; 32(6): 673–80.

Kost K, Parham K. Presbyphonia: What can be done? Ear Nose Throat J 2017; 96(3): 108–10.

Belafsky PC, Postma GN, Reulbach TR, Holland BW, Koufman JA. Muscle tension dysphonia as a sign of underlying glottal insufficiency. Otolaryngol Head Neck Surg 2002; 127(5): 448–51.

Rapoport SK, Menier J, Grant N. Voice Changes in the Elderly. Otolaryngol Clin North Am 2018; 51(4): 759–68.

Mozzanica F, Ginocchio D, Barillari R, Barozzi S, Maruzzi P, Ot-taviani F, et al. Prevalence and Voice Characteristics of Laryn-geal Pathology in an Italian Voice Therapy-seeking Popula-tion. J Voice 2016; 30(6): 774.e13–21.

Misono S, Peterson CB, Meredith L, Banks K, Bandyopadhyay D, Yueh B, et al. Psychosocial distress in patients presenting with voice concerns. J Voice 2014; 28(6): 753–61.

Dietrich M, Verdolini Abbott K, Gartner-Schmidt J, Rosen CA. The frequency of perceived stress, anxiety, and depression in patients with common pathologies affecting voice. J Voice 2008; 22(4): 472–88.

Mora R, Crippa B, Cervoni E, Santomauro V, Guastini L. Acous-tic features of voice in patients with severe hearing loss. J Otolaryngol Head Neck Surg 2012; 41(1): 8–13.

Ross J, Valentino WL, Calder A, Bigly D, Othman S, McKinnon B, et al. Utility of Audiometry in the Evaluation of Patients Pre-senting with Dysphonia. Ann Otol Rhinol Laryngol 2020; 129(4): 333–9.

Hengen J, Hammarström IL, Stenfelt S. Perceived Voice Quality and Voice-Related Problems Among Older Adults with Hear-ing Impairments. J Speech Lang Hear Res 2018; 61(9): 2168–78.

Statistical Office of the Republic of Serbia; Milić N, Stanisavljević D, Krstić M, Jovanović V, Brcanski J, Kilibarda B, et al. The 2019 Serbian National Health Survey [Internet]. Belgrade: OMNIA BGD; 2021 [cited 2025 Jan 29]. Available from: https://publikacije.stat.gov.rs/G2021/pdfE/G20216003.pdf

Simberg S, Sala E, Tuomainen J, Rönnemaa AM. Vocal symptoms and allergy--a pilot study. J Voice 2009; 23(1): 136–9.

Bhalla RK, Watson G, Taylor W, Jones AS, Roland NJ. Acoustic analysis in asthmatics and the influence of inhaled corticoster-oid therapy. J Voice 2009; 23(4): 505–11.

Krouse JH, Altman KW. Rhinogenic laryngitis, cough, and the unified airway. Otolaryngol Clin North Am 2010; 43(1): 111–21, ix–x.

Spantideas N, Bougea A, Drosou E, Assimakopoulos D. The Role of Allergy in Phonation. J Voice 2019; 33(5): 811.e19–27.

Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, et al. International Consensus Statement on Allergy and Rhinol-ogy: Allergic Rhinitis. Int Forum Allergy Rhinol 2018; 8(2): 108–352.

Ohlsson AC, Drevsäter A, Brynnel M, Johansson I. Allergic rhini-tis and voice change. Logoped Phoniatr Vocol 2016; 41(4): 143–8.

Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet 2017; 390(10101): 1550–62.

Barić A, Brčić L, Gračan S, Škrabić V, Brekalo M, Šimunac M, et al. Thyroglobulin Antibodies are Associated with Symptom Burden in Patients with Hashimoto's Thyroiditis: A Cross-Sectional Study. Immunol Invest 2019; 48(2): 198–209.

Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, et al. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011; 21(2): 161–7. Erratum in: Thyroid 2011; 21(4): 467.

Guldvog I, Reitsma LC, Johnsen L, Lauzike A, Gibbs C, Carlsen E, et al. Thyroidectomy Versus Medical Management for Eu-thyroid Patients with Hashimoto Disease and Persisting Symp-toms: A Randomized Trial. Ann Intern Med 2019; 170(7): 453–64.

Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Da-yan CM. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002; 57(5): 577–85.

Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, et al. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 2004; 4: 25.

Hom C, Vaezi MF. Extraesophageal manifestations of gas-troesophageal reflux disease. Gastroenterol Clin North Am 2013; 42(1): 71–91.

Hanna BC, Wormald PJ. Gastroesophageal reflux and chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2012; 20(1): 15–8.

Objavljeno
2025/05/29
Rubrika
Originalni članak